At Meins, we believe that business growth should go hand in hand with a genuine commitment to society. That is why, once again, we are reinforcing cancer research in Salamanca through an annual financial contribution to the Pathology Unit and the Castilla y León Biobank Network at the Cancer Research Center (CIC). This partnership is now entering its second consecutive year and reflects our long-term commitment to supporting scientific research.
Supporting the Science That Saves Lives
Our contribution comparable in scale to the annual funding provided by the Regional Government of Castilla y León is specifically allocated to the Molecular Pathology Laboratory and the Regional Biobank. These two cornerstone facilities play a vital role in tumour research and in the development of biomarkers and personalised cancer treatments.
In practical terms, our support helps fund the highly specialised scientific staff whose work makes it possible for oncology research to continue advancing in Salamanca every day.
We understand that research units of this calibre cannot rely solely on isolated projects or one-off donations. They require stable, long-term funding to ensure continuity and sustained progress. That is why Meins is committed to being more than an occasional donor—we aim to provide ongoing support that enables dozens of researchers to carry out their work with confidence and stability.
Twenty-Five Years of the Salamanca Tumour Bank: A Shared Legacy
This year’s contribution carries special significance as it coincides with the 25th anniversary of the Salamanca Tumour Bank, which has collected more than 30,000 tissue samples generously donated by patients over the past quarter-century.
Every one of these samples represents an act of generosity that has helped drive progress in cancer research while enabling more accurate diagnoses and more effective, personalised treatments. It is this shared mission that Meins is proud to support, and we believe contributions like ours should help sustain this collective effort for years to come.
Why We Support Cancer Research
At Meins, we firmly believe that advancing cancer research is a priority that affects us all, and that businesses in Salamanca have an important role to play in supporting it.
This is, above all, an investment in the future. Every scientific breakthrough achieved in Salamanca brings us closer to better treatments, improved patient outcomes, and ultimately, more lives saved.
This partnership also reinforces our commitment to the United Nations Sustainable Development Goals, particularly:
- SDG 17: Partnerships for the Goals
- SDG 3: Good Health and Well-being
Year after year, we will continue supporting initiatives that strengthen cancer research in Salamanca, convinced that this is a path more businesses in our community should embrace.
Frequently Asked Questions About Meins’ Support for Cancer Research in Salamanca
What does Meins’ contribution to the Cancer Research Center involve?
It is an annual financial donation to the Pathology Unit and the Castilla y León Biobank Network at the Salamanca Cancer Research Center (CIC), helping fund the specialised scientific staff responsible for advancing cancer research.
Which specific projects benefit from this contribution?
The funding is primarily allocated to the Molecular Pathology Laboratory and the Regional Biobank, two key facilities dedicated to tumour research and the development of biomarkers and personalised cancer therapies.
How long has Meins been supporting cancer research in Salamanca?
This partnership is now entering its second consecutive year and has been established as a long-term annual commitment.
What is the Salamanca Tumour Bank?
The Salamanca Tumour Bank is part of the Cancer Research Center (CIC). Celebrating its 25th anniversary, it has collected more than 30,000 tissue samples voluntarily donated by patients, providing an invaluable resource for the development of biomarkers and personalised cancer treatments.
Why does Meins support cancer research?
Because we believe that the fight against cancer is one of the defining challenges facing society, and that businesses have a responsibility to dedicate part of their resources to supporting scientific research that has a direct and lasting impact on people’s lives.
